Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer

Cancer is one of the most fatal diseases with an increasing incidence and mortality all over the world. Thus, there is an urgent need for novel therapies targeting major cancer-related pathways. Nuclear factor-erythroid 2-related factor 2 (NRF2) and its major negative modulator Kelch-like ECH-associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Telkoparan-Akillilar, Pelin, Panieri, Emiliano, Cevik, Dilek, Suzen, Sibel, Saso, Luciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961421/
https://www.ncbi.nlm.nih.gov/pubmed/33808001
http://dx.doi.org/10.3390/molecules26051417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961421/
https://www.ncbi.nlm.nih.gov/pubmed/33808001
http://dx.doi.org/10.3390/molecules26051417

Ejemplares similares